Package 71209-102-21

Brand: erythromycin ethylsuccinate

Generic: erythromycin ethylsuccinate
NDC Package

Package Facts

Identity

Package NDC 71209-102-21
Digits Only 7120910221
Product NDC 71209-102
Product ID 71209-102_f9139eef-80df-428d-a326-a70cc827f9c9
Description

100 mL in 1 BOTTLE (71209-102-21)

Marketing

Marketing Status
Marketed Since 2022-11-21
Brand erythromycin ethylsuccinate
Generic erythromycin ethylsuccinate
Sample Package No

Linked Drug Pages (1)

Erythromycin ethylsuccinate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f9139eef-80df-428d-a326-a70cc827f9c9", "openfda": {"upc": ["0371209103213"], "unii": ["1014KSJ86F"], "rxcui": ["686400", "686418"], "spl_set_id": ["db70798e-5e07-41d6-afe9-82c272bc5cc0"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (71209-102-21)", "package_ndc": "71209-102-21", "marketing_start_date": "20221121"}], "brand_name": "Erythromycin ethylsuccinate", "product_id": "71209-102_f9139eef-80df-428d-a326-a70cc827f9c9", "dosage_form": "FOR SUSPENSION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "71209-102", "generic_name": "Erythromycin ethylsuccinate", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin ethylsuccinate", "active_ingredients": [{"name": "ERYTHROMYCIN ETHYLSUCCINATE", "strength": "200 mg/5mL"}], "application_number": "ANDA216212", "marketing_category": "ANDA", "marketing_start_date": "20221121", "listing_expiration_date": "20261231"}